In core drug-research-focused imaging facilities, multiple imaging modalities are woven together in single studies to address numerous, complementary aspects of the drug-target interaction and the degree of subsequent disease inhibition. Multi-modality imaging provides an opportunity to non-invasively generate simultaneous anatomical, functional and molecular end points, with inherent spatial resolution. This approach leads to unique and powerful datasets that can be used for more effective decision making in drug research. For over a decade, Molecular Imaging has harnessed the power of multi-modality imaging. We continue to leverage and build on this concept to meet and exceed our clients’ need through the generation of superior multi-modality datasets.
